News

The research, development and production of biological products has grown dramatically in recent years, and Brazil has accompanied this growth. To ensure the safety of these products, we need to implement quality rules that are standardized worldwide and recognized by our Health Surveillance Agency (ANVISA), and by international regulatory bodies. To ensure high quality research… Continue reading Biotimize in South Korea – GTH-B

In early 2023, we partnered with Sthorm to build the first CDMO for biopharmaceuticals in Brazil! Together we seek to develop new approaches to create a scenario where it is possible to democratize access to science and healing. That’s how we’re going to make a positive impact on people’s lives. With a new brand and a clear… Continue reading Biotimize’s New Era

In an unprecedented model in the country, Biotimize opens a laboratory to development of active biological inputs in Brazil Company is the first to work under GLP certification in Brazil to operate in the “as a service” model (CDMO) and will be the only one in South America to offer an end-to-end production service from… Continue reading Biotimize’s R&D Center inauguration

We are used to talk about Good Manufacturing Practice (GMP), however, have you thought the importance of the Good Laboratory Practice (GLP)? While GLP and GMP serve different purposes and address different stages of product development and manufacturing, they are both essential components of the regulatory framework governing the biopharmaceutical industry. GMP ensures the consistent… Continue reading Good Laboratory Practice (GLP)